GFI1 and Miyoshi myopathy: Future experiments using additional samples from patients with variety of MM disease stages and skeletal involvement may provide valuable information about the importance of blocking the p62-ZZ-GFI1 signaling axis in MM-BMSC interactions in the clinical setting.